1748-720X/asset/JLME_centre.gif?v=1&s=61303f09c2cdbfcc036b6a2fea7f0da707851d7a)
Conflicts of Interest, Institutional Corruption, and Pharma: An Agenda for Reform
Article first published online: 12 OCT 2012
DOI: 10.1111/j.1748-720X.2012.00683.x
© 2012 American Society of Law, Medicine & Ethics, Inc.
Issue
The Journal of Law, Medicine & Ethics
Special Issue: SYMPOSIUM 1: Conflicts of Interest in the Practice of Medicine
Volume 40, Issue 3, pages 511–522, Fall 2012
Additional Information
How to Cite
Rodwin, M. A. (2012), Conflicts of Interest, Institutional Corruption, and Pharma: An Agenda for Reform. The Journal of Law, Medicine & Ethics, 40: 511–522. doi: 10.1111/j.1748-720X.2012.00683.x
Publication History
- Issue published online: 12 OCT 2012
- Article first published online: 12 OCT 2012
- Abstract
- References
- Cited By
When physicians' conflicts of interest arise from ties with drug firms, we should shift our focus to the pharmaceutical industry and improper dependencies that cause institutional corruption. This article analyzes eight forms of improper dependencies on pharma and proposes reforms.